跳转至内容
Merck
CN

HKI4MAG-99K

MILLIPLEX® Human Kidney Injury Panel

Configurable Human Kidney Toxicity 7-plex Panel 4

登录 查看公司和协议定价

关于此项目

UNSPSC代码:
12161503
eCl@ss:
32161000
NACRES:
NA.84
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

种属反应性

human

包装

pkg of 1 ea

制造商/商品名称

Milliplex®

assay range

accuracy: 63-118%
intra-assay cv: <10
sensitivity: 0.01-0.71 ng/mL
(MinDC+2SD)

standard curve range: 0.01-5 ng/mL
(IP-10)

standard curve range: 0.012-12.5 ng/mL
(EGF)

standard curve range: 0.02-20 ng/mL
(PTH)

standard curve range: 0.15-150 ng/mL
(FABP1)

standard curve range: 0.17-1,200 ng/mL
(Osteopontin (OPN))

standard curve range: 0.20-200 ng/mL
(KIM-1)

standard curve range: 0.68-700 ng/mL
(Renin)

技术

multiplexing: suitable

输入

serum

检测方法

fluorometric (Luminex® xMAP® technology)

运输

wet ice

储存温度

2-8°C

一般描述

Albumin, Beta-2 Microglobulin, Clusterin, Cystatin C, and Lipocalin-2/NGAL are important biomarkers for evaluating kidney function, tubular integrity, and early signs of renal injury. These analytes help detect glomerular filtration changes, proteinuria, and inflammation, making them valuable for monitoring acute and chronic kidney conditions. Their combined assessment supports sensitive and specific evaluation of renal health.

应用

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in human serum or plasma samples.Analytes included: α-1-Microglobulin, Albumin, Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, Osteopontin (OPN)Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

特点和优势

Features:
Measures 7 key biomarkers of kidney injury in human urine samples

Includes α-1-Microglobulin, Albumin, Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, and Osteopontin (OPN)

Magnetic bead-based format for enhanced precision and simplified washing

Utilizes Luminex® xMAP® technology for multiplexing and high-throughput analysis

Validated for human urine with recommended sample dilution of 1:100

Assay sensitivity ranges from 0.015 to 5.359 ng/mL depending on the analyte

Standard curve ranges from 0.01 to 5,000 ng/mL across analytes

Intra-assay CV < 10%, inter-assay CV < 20%

Benefits:

Enables early and specific detection of kidney injury before traditional markers like BUN and serum creatinine

Provides insight into organ-specific damage and mechanisms of nephrotoxicity

Conserves sample volume by analyzing multiple biomarkers in a single run

Supports drug safety and toxicity research with high analytical performance

Reduces assay variability and improves reproducibility across studies

Compatible with both manual and automated workflows for flexible lab integration

法律信息

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

免责声明

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

警示用语:

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

靶器官

Respiratory Tract

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Annie Moisan et al.
Molecular therapy. Nucleic acids, 6, 89-105 (2017-03-23)
Antisense oligonucleotide (AON) therapeutics offer new avenues to pursue clinically relevant targets inaccessible with other technologies. Advances in improving AON affinity and stability by incorporation of high affinity nucleotides, such as locked nucleic acids (LNA), have sometimes been stifled by

相关内容

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持